Chiu-Mei Yeh
Overview
Explore the profile of Chiu-Mei Yeh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
701
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Teng C, Yeh C, Liu C, Chen T, Huang N, Chou Y
Postgrad Med J
. 2025 Jan;
PMID: 39790005
Background: Thyroid cancer primarily affects young women and raises concerns about future fertility due to treatments of thyroidectomy and radioactive iodine (RAI) therapy. This study investigated the effects of these...
2.
Yang T, Tsai C, Wang H, Ko P, Chien S, Lin T, et al.
Ann Hematol
. 2024 Sep;
103(11):4661-4670.
PMID: 39223286
Hematopoietic stem cell transplantation (HSCT) is pivotal in treating hematologic disorders, yet it poses the risk of post-transplantation pancytopenia. Prophylactic platelet transfusions are often administered to mitigate this risk. Utilizing...
3.
Huang J, Yeh C, Gong Y, Tsai M, Lin Y, Tsai C, et al.
Ann Hematol
. 2024 Aug;
103(10):4099-4109.
PMID: 39158713
Bendamustine is used to treat lymphoma with excellent efficacy but is known for its immunosuppressive effect. Cytomegalovirus (CMV) reactivation after bendamustine use has been reported. We aim to address the...
4.
Yeh C, Lai T, Hu Y, Teng C, Huang N, Liu C
Sci Rep
. 2024 Apr;
14(1):8227.
PMID: 38589462
Colorectal cancer (CRC) patients who receive cancer surgeries from higher-volume providers may have better outcomes. However, the definitions of surgical volume may affect the results. We aim to analyze the...
5.
Wu C, Yeh C, Tsai C, Liu C
Ann Hematol
. 2024 Mar;
103(5):1577-1586.
PMID: 38532122
Acute promyelocytic leukemia (APL) is a highly curable hematologic malignancy in the era of all-trans retinoic acid (ATRA) combination treatment. However, only a modest change in early mortality rate has...
6.
Hsu T, Tsai C, Liu C, Yeh C, Lin F, Hsiao L, et al.
Ann Hematol
. 2024 Mar;
103(8):2893-2904.
PMID: 38472362
Multiple myeloma (MM) stands as the second most prevalent hematological malignancy, constituting approximately 10% of all hematological malignancies. Current guidelines recommend upfront autologous stem cell transplantation (ASCT) for transplant-eligible MM...
7.
Hu Y, Yeh C, Liu C, Chen T, Huang N, Chou Y
Cancer Epidemiol Biomarkers Prev
. 2024 Feb;
33(5):739-748.
PMID: 38412010
Background: The literature on the association between diabetes severity and cancer risk is limited and inconclusive. The study aimed to evaluate the association between the adapted Diabetes Complications Severity Index...
8.
Chen Y, Chou Y, Yeh C, Huang N
Am J Manag Care
. 2023 Jul;
29(7):e215-e221.
PMID: 37523454
Objectives: Postacute care (PAC) heavily relies on effective connection between acute and postacute providers. However, little is known about whether and to what extent providers' patient-sharing relationships influence patient outcomes....
9.
Hu Y, Yeh C, Liu C, Chen T, Huang N, Chou Y
BMJ Open Diabetes Res Care
. 2023 Mar;
11(2).
PMID: 36977521
Introduction: Adapted Diabetes Complications Severity Index (aDCSI) is a commonly used severity measure based on the number and severity of diabetes complications using diagnosis codes. The validity of aDCSI in...
10.
Hsu T, Tsai C, Liu C, Yeh C, Lin F, Hsiao L, et al.
Transfus Med Hemother
. 2023 Feb;
50(1):39-50.
PMID: 36818774
Introduction: Autologous hematopoietic stem cell transplantation (ASCT) is a well-established treatment for patients with multiple myeloma (MM), and adequate stem cell collection must be assured before ASCT. However, prediction of...